09/15/2021 | Press release | Distributed by Public on 09/14/2021 23:46
The 11th edition is dedicated to our exciting new capabilities in the biologics lane of Evotec's 'Multi-modality Autobahn.'
For the biologics industry, Evotec provides a fast lane to drug discovery and development solutions. No matter where the project lies on the idea-to-IND continuum and beyond, Evotec's experience supports all activities from target identification through to IND submission, with high-end manufacturing completing this one-stop-shop.
This comprehensive offering enables our partners to work with one experienced team for more efficient, productive, faster, and flexible biologics drug discovery, development and manufacturing.